The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Feeling cold 13
SANDOSTATIN LAR DEPOT Frustration tolerance decreased 13
SANDOSTATIN LAR DEPOT Gout 13
SANDOSTATIN LAR DEPOT Hepatic pain 13
SANDOSTATIN LAR DEPOT Rectal haemorrhage 13
SANDOSTATIN LAR DEPOT Renal failure 13
SANDOSTATIN LAR DEPOT Respiratory tract congestion 13
SANDOSTATIN LAR DEPOT Sinusitis 13
SANDOSTATIN LAR DEPOT Swelling face 13
SANDOSTATIN LAR DEPOT Thyroid mass 13
SANDOSTATIN LAR DEPOT Transient ischaemic attack 13
SANDOSTATIN Blood pressure decreased 12
SANDOSTATIN Cholelithiasis 12
SANDOSTATIN Faeces discoloured 12
SANDOSTATIN Feeling hot 12
SANDOSTATIN Frequent bowel movements 12
SANDOSTATIN Second primary malignancy 12
SANDOSTATIN Tremor 12
SANDOSTATIN LAR DEPOT Bacterial infection 12
SANDOSTATIN LAR DEPOT Bile duct obstruction 12

Total Records: 2,045     Number of Pages: 103